Back to results
Not yet recruitingEARLY_Phase 1

The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors

NCT07459283

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Affiliated Hospital of Jiangnan University

Wuxi, Jiangsu, China

View on ClinicalTrials.gov
The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors — TrialFind